BIM
ELV icon

Baldwin Investment Management’s Elevance Health ELV Stock Holding History

Baldwin Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-503
Closed -$223K – 195
2023
Q2 		$223K Hold
503
– – 0.04% 183
2023
Q1 		$231K Sell
503
-147
-23% -$70K 0.04% 188
2022
Q4 		$333K Sell
650
-100
-13% -$50.8K 0.06% 162
2022
Q3 		$341 Sell
750
-611
-45% -$292K 0.07% 154
2022
Q2 		$657 Sell
1,361
-50
-4% -$24.7K 0.12% 118
2022
Q1 		$693 Sell
1,411
-32
-2% -$14.6K 0.1% 130
2021
Q4 		$669 Hold
1,443
– – 0.1% 137
2021
Q3 		$538K Sell
1,443
-52
-3% -$19.8K 0.09% 148
2021
Q2 		$571K Buy
1,495
+10
+0.7% +$3.82K 0.1% 147
2021
Q1 		$533K Buy
1,485
+585
+65% +$188K 0.1% 146
2020
Q4 		$289K Buy
900
+150
+20% +$46K 0.06% 197
2020
Q3 		$201K Buy
+750
New +$202K 0.05% 202

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baldwin Investment Management's ELV Position: Q3 2023 in Review

Baldwin Investment Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 503 shares — an estimated $223K sold.

Baldwin Investment Management first reported a position in ELV in Q3 2020 and held it in 12 quarters. The position peaked at $571K in Q2 2021. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Baldwin Investment Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Baldwin Investment Management sold 503 Elevance Health shares in Q3 2023, an estimated $223K.
  • Baldwin Investment Management first reported a position in Elevance Health in Q3 2020 and held it in 12 quarters.
  • Baldwin Investment Management's Elevance Health position peaked at $571K in Q2 2021.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Baldwin Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.